These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 24160954)

  • 1. [Colorectal cancer screening].
    Castells A
    Gastroenterol Hepatol; 2013 Oct; 36 Suppl 2():66-72. PubMed ID: 24160954
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The usefulness of fecal tests in colorectal cancer screening].
    Castells A
    Gastroenterol Hepatol; 2014 Sep; 37 Suppl 3():71-6. PubMed ID: 25294268
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Colorectal cancer screening].
    Castells A
    Gastroenterol Hepatol; 2012 Sep; 35 Suppl 1():68-73. PubMed ID: 23018010
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Colorectal cancer screening].
    Castells A
    Gastroenterol Hepatol; 2015 Sep; 38 Suppl 1():64-70. PubMed ID: 26520198
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Colorectal cancer screening].
    Castells A
    Gastroenterol Hepatol; 2011 Oct; 34 Suppl 2():60-6. PubMed ID: 22330158
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Colorectal cancer screening: present strategies and future prospects.
    Marshall JB
    Postgrad Med; 1996 Mar; 99(3):253-64. PubMed ID: 8637834
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Flexible sigmoidoscopy versus fecal occult blood testing for colorectal cancer screening in asymptomatic individuals.
    Stern C
    Clin J Oncol Nurs; 2014 Aug; 18(4):471-2. PubMed ID: 25095304
    [TBL] [Abstract][Full Text] [Related]  

  • 8. One-time screening for colorectal cancer with combined fecal occult-blood testing and examination of the distal colon.
    Lieberman DA; Weiss DG;
    N Engl J Med; 2001 Aug; 345(8):555-60. PubMed ID: 11529208
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is the type of test used for mass colorectal cancer screening a determinant of compliance? A cluster-randomized controlled trial comparing fecal occult blood testing with flexible sigmoidoscopy.
    Federici A; Marinacci C; Mangia M; Borgia P; Giorgi Rossi P; Guasticchi G
    Cancer Detect Prev; 2006; 30(4):347-53. PubMed ID: 16965874
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cost-effectiveness analysis of colorectal cancer screening methods in Iran.
    Allameh Z; Davari M; Emami MH
    Arch Iran Med; 2011 Mar; 14(2):110-4. PubMed ID: 21361717
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Test performance of immunologic fecal occult blood testing and sigmoidoscopy compared with primary colonoscopy screening for colorectal advanced adenomas.
    Khalid-de Bakker CA; Jonkers DM; Sanduleanu S; de Bruïne AP; Meijer GA; Janssen JB; van Engeland M; Stockbrügger RW; Masclee AA
    Cancer Prev Res (Phila); 2011 Oct; 4(10):1563-71. PubMed ID: 21750209
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Colorectal cancer screening.
    Bessa Caserras X
    Gastroenterol Hepatol; 2016 Sep; 39 Suppl 1():68-78. PubMed ID: 27888867
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Randomized trial of different screening strategies for colorectal cancer: patient response and detection rates.
    Segnan N; Senore C; Andreoni B; Arrigoni A; Bisanti L; Cardelli A; Castiglione G; Crosta C; DiPlacido R; Ferrari A; Ferraris R; Ferrero F; Fracchia M; Gasperoni S; Malfitana G; Recchia S; Risio M; Rizzetto M; Saracco G; Spandre M; Turco D; Turco P; Zappa M;
    J Natl Cancer Inst; 2005 Mar; 97(5):347-57. PubMed ID: 15741571
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Necessity and feasibility of screening for colorectal cancer in China].
    Zhang SZ
    Zhonghua Wei Chang Wai Ke Za Zhi; 2011 Jan; 14(1):16-8. PubMed ID: 21271373
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Chemical or immunological tests for the detection of fecal occult blood in colorectal cancer screening?].
    Quintero E
    Gastroenterol Hepatol; 2009 Oct; 32(8):565-76. PubMed ID: 19577340
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Survey of internal medicine residents' use of the fecal occult blood test and their understanding of colorectal cancer screening and surveillance.
    Sharma VK; Corder FA; Raufman JP; Sharma P; Fennerty MB; Howden CW
    Am J Gastroenterol; 2000 Aug; 95(8):2068-73. PubMed ID: 10950059
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Testing for faecal calprotectin (PhiCal) in the Norwegian Colorectal Cancer Prevention trial on flexible sigmoidoscopy screening: comparison with an immunochemical test for occult blood (FlexSure OBT).
    Hoff G; Grotmol T; Thiis-Evensen E; Bretthauer M; Gondal G; Vatn MH
    Gut; 2004 Sep; 53(9):1329-33. PubMed ID: 15306594
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Survey of the opinions, knowledge, and practices of gastroenterologists regarding colorectal cancer screening and use of the fecal occult blood test.
    Sharma VK; Corder FA; Fancher J; Howden CW
    Am J Gastroenterol; 2000 Dec; 95(12):3629-32. PubMed ID: 11151904
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Prevention of colorectal carcinoma. Annual hemoccult test and sigmoidoscopy every 5 years].
    Rosenbaum A; Riemann JF
    MMW Fortschr Med; 2000 Aug; 142(31-32):27-9. PubMed ID: 10992763
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The price of autonomy: should we offer individuals a choice of colorectal cancer screening strategies?
    van Dam L; Kuipers EJ; Steyerberg EW; van Leerdam ME; de Beaufort ID
    Lancet Oncol; 2013 Jan; 14(1):e38-46. PubMed ID: 23276372
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.